- Lantheus increases to 12.16% shareholding in Radiopharm Theranostics (NASDAQ:RADX) with a $5M placement (A$8.0 million).
- The placement of 133 million shares was completed at an issue price of A$0.060 per share, representing a 150% premium to the last traded price of RAD shares (A$0.024). Settlement is expected to occur within 7 days.
- Filing